Proteome analysis of retinal glia cells-related inflammatory cytokines in the aqueous humour of diabetic patients

Acta Ophthalmologica

Volumn 94, Issue 1, 2016, Pages 56-64

  Vujosevic, Stela ^a   Micera, Alessandra ^b   Bini, Silvia ^a   Berton, Marianna ^a   Esposito, Graziana ^b   Midena, Edoardo ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b IRCCS FONDAZIONE BIETTI   (Italy)

Author keywords

aqueous humour; diabetic retinopathy; inflammation; microglia; Muller cells; proteomic; retinal glia cells

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOGLOBIN A1C; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 15; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 3; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; RANTES; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; PROTEOME;

AGED; AQUEOUS HUMOR; ARTICLE; CASE CONTROL STUDY; CATARACT EXTRACTION; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOKINE RELEASE; DIABETIC PATIENT; EYE EXAMINATION; FEMALE; GLIA CELL; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OPEN STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; RETINA CELL; DIABETIC RETINOPATHY; GLIA; METABOLISM; MIDDLE AGED; PROTEIN MICROARRAY; RETINA NERVE CELL;

AGED; AQUEOUS HUMOR; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; CYTOKINES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROGLIA; PROSPECTIVE STUDIES; PROTEIN ARRAY ANALYSIS; PROTEOME; RETINAL NEURONS;

EID: 84955638152     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/aos.12812     Document Type: Article

References (62)

1. Adamiec-Mroczek J, Oficjalska-Mlynczak J, &, Misiuk-Hojlo M, (2010): Roles of endothelin-1 and selected proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy: analysis of vitreous samples. Cytokine 49: 269-274.
2. American Diabetes Association (2012): Diagnosis and classification of diabetes mellitus. Diabetes Care 35: S64-S71.
3. Aveleira CA, Lin CM, Abcouwer SF, Ambrõsio AF, &, Antonetti DA, (2010): TNF-α signals through PKCζ/NF-κB to alter the tight junction complex and increase retinal endothelial cell permeability. Diabetes 59: 2872-2882.
4. Benjamini Y, &, Hochberg Y, (1995): Controlling the false discovering rate: a practical and powerful approach to multiple testing. J Roy Stat Soc 57: 289-300.
5. Bringmann A, &, Wiedemann P, (2012): Müller glial cells in retinal disease. Ophthalmologica 227: 1-19.
6. Bringmann A, Iandiev I, Pannicke T, Hollborn M, Wiedemann P, Osborne NN, &, Reichenbach A, (2009): Cellular signaling and factors involved in Muller cell gliosis: neuroprotective and detrimental effects. Prog Retin Eye Res 28: 423-451.
7. Cardona AE, Pioro EP, Sasse ME, et al., (2006): Control of microglial neurotoxicity by the fractalkine receptor. Nat Neurosci 9: 917-924.
8. Cheung CM, Vania M, Ang M, Chee SP, &, Li J, (2012): Comparison of aqueous humor cytokine and chemokine levels in diabetic patients with and without retinopathy. Mol Vis 18: 830-837.
9. Chiang SY, Tsai ML, Wang CY, et al., (2012): Proteomic analysis and identification of aqueous humor proteins with a pathophysiological role in diabetic retinopathy. J Proteomics 75: 2950-2959.
10. Cui X, &, Churchill GA, (2003): Statistical tests for differential expression in cDNA microarray experiments. Genome Biol 4: 210.
11. Demircan N, Safran BG, Soylu M, Ozcan AA, &, Sizmaz S, (2006): Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy. Eye 20: 1366-1369.
12. Ecker SM, Hines JC, Pfahler SM, &, Glaser BM, (2011): Aqueous cytokine and growth factor levels do not reliably reflect those levels found in the vitreous. Mol Vis 17: 2856-2863.
13. El-Asrar AM, (2012): Role of inflammation in the pathogenesis of diabetic retinopathy. Middle East Afr J Ophthalmol 19: 70-74.
14. El-Asrar AM, Nawaz MI, Kangave D, Geboes K, Ola MS, Ahmad S, &, Al-Shabrawey M, (2011): High-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy. Mol Vis 17: 1829-1838.
15. Forooghian F, Kertes PJ, Eng KT, Agrõn E, &, Chew EY, (2010): Alterations in the intraocular cytokine milieu after intravitreal bevacizumab. Invest Ophthalmol Vis Sci 51: 2388-2392.
16. Funatsu H, Yamashita H, Noma H, Mimura T, Yamashita T, &, Hori S, (2002): Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema. Am J Ophthalmol 133: 70-77.
17. Funatsu H, Yamashita H, Sakata K, Noma H, Mimura T, Suzuki M, Eguchi S, &, Hori S, (2005a): Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema. Ophthalmology 112: 806-816.
18. Funatsu H, Yamashita H, Noma H, Mimura T, Nakamura S, Sakata K, &, Hori S, (2005b): Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients. Graefes Arch Clin Exp Ophthalmol 243: 3-8.
19. Funatsu H, Noma H, Mimura T, Eguchi S, &, Hori S, (2009): Association of vitreous inflammatory factors with diabetic macular edema. Ophthalmology 116: 73-79.
20. Garcia JA, Pino PA, Mizutani M, Cardona SM, Charo IF, Ransohoff RM, Forsthuber TG, &, Cardona AE, (2013): Regulation of adaptive immunity by the fractalkine receptor during autoimmune inflammation. J Immunol 191: 1063-1072.
21. Grigsby JG, Cardona SM, Pouw CE, Muniz A, Mendiola AS, Tsin AT, Allen DM, &, Cardona AE, (2014): The role of microglia in diabetic retinopathy. J Ophthalmol 2014: 705783.
22. Grus FH, Joachim SC, &, Pfeiffer N, (2007): Proteomics in ocular fluids. Proteomics Clin Appl 1: 876-888.
23. Gverovic AA, Karaman K, Znaor L, Sapunar A, Buško V, &, Puzovic V, (2012): IL-12 concentrations in the aqueous humor and serum of diabetic retinopathy patients. Graefes Arch Clin Exp Ophthalmol 250: 815-821.
24. Hang H, Yuan S, Yang Q, Yuan D, &, Liu Q, (2014): Multiplex bead array assay of plasma cytokines in type 2 diabetes mellitus with diabetic retinopathy. Mol Vis 20: 1137-1145.
25. Hanisch UK, &, Kettenmann H, (2007): Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10: 1387-1394.
26. Ibrahim AS, El-Remessy AB, &, Matragoon S, (2011): Retinal microglial activation and inflammation induced by amadori-glycated albumin in a rat model of diabetes. Diabetes 60: 1122-1133.
27. Inoue M, Azumi A, Shirabe H, Tsukahara Y, &, Yamamoto M, (1994): Laser flare intensity in diabetics: correlation with retinopathy and aqueous protein concentration. Br J Ophthalmol 78: 694-697.
28. Jonas JB, Jonas RA, Neumaier M, &, Findeisen P, (2012): Cytokine concentration in aqueous humor of eyes with diabetic macular edema. Retina 32: 2150-2157.
29. Karlstetter M, Lippe E, Walczak Y, Moehle C, Aslanidis A, Mirza M, &, Langmann T, (2011): Curcumin is a potent modulator of microglial gene expression and migration. J Neuroinflammation 29: 8-125.
30. Karlstetter M, Scholz R, Rutar M, Wong WT, Provis JM, &, Langmann T, (2015): Retinal microglia: just bystander or target for therapy? Prog Retin Eye Res 45: 30-57.
31. Kern TS, (2007): Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res 95: 103.
32. Kowluru RA, &, Odenbach S, (2004): Role of interleukin-1beta in the pathogenesis of diabetic retinopathy. Br J Ophthalmol 88: 1343-1347.
33. Krady JK, Basu A, Allen CM, Xu Y, LaNoue KF, Gardner TW, &, Levison SW, (2005): Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes 54: 1559-1565.
34. Kremlev SG, Roberts RL, &, Palmer C, (2004): Differential expression of chemokines and chemokine receptors during microglial activation and inhibition. J Neuroimmunol 149: 1-9.
35. Langmann T, (2007): Microglia activation in retinal degeneration. J Leukoc Biol 81: 1345-1351.
36. Liu Y, Biarnés Costa M, &, Gerhardinger C, (2012): IL-1β is upregulated in the diabetic retina and retinal vessels: cell-specific effect of high glucose and IL-1β autostimulation. PLoS ONE 7: e36949.
37. Maier R, Weger M, Haller-Schober EM, et al., (2008): Multiplex bead analysis of vitreous and serum concentrations of inflammatory and proangiogenic factors in diabetic patients. Mol Vis 14: 637-643.
38. Martinez-Moczygemba M, &, Huston DP, (2003): Biology of common beta receptor-signaling cytokines: IL-3, IL-5, and GM-CSF. J Allergy Clin Immunol 112: 653-665.
39. Maurer M, &, von Stebut E, (2004): Macrophage inflammatory protein-1. Int J Biochem Cell Biol 36: 1882-1886.
40. Murugeswari P, Shukla D, Rajendran A, Kim R, Namperumalsamy P, &, Muthukkaruppan V, (2008): Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease. Retina 28: 817-824.
41. Noma H, Funatsu H, Mimura T, Harino S, &, Hori S, (2009): Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion. Ophthalmology 116: 87-93.
42. Oh IK, Kim SW, Oh J, Lee TS, &, Huh K, (2010): Inflammatory and angiogenic factors in the aqueous humor and the relationship to diabetic retinopathy. Curr Eye Res 35: 1116-1127.
43. Patel JI, Tombran-Tink J, Hykin PG, Gregor ZJ, &, Cree IA, (2006): Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: implications for structural differences in macular profiles. Exp Eye Res 82: 798-806.
44. Patel JI, Saleh GM, Hykin PG, Gregor ZJ, &, Cree IA, (2008): Concentration of haemodynamic and inflammatory related cytokines in diabetic retinopathy. Eye (Lond) 22: 223-228.
45. Pereira Tde O, da Costa GN, Santiago AR, Ambrõsio AF, &, dos Santos PF, (2010): High glucose enhances intracellular Ca2 + responses triggered by purinergic stimulation in retinal neurons and microglia. Brain Res 1316: 129-138.
46. Rangasamy S, McGuire PG, &, Das A, (2012): Diabetic retinopathy and inflammation: novel therapeutic targets. Middle East Afr J Ophthalmol 19: 52-59.
47. Rothwell NJ, &, Luheshi GN, (2000): Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci 23: 618-625.
48. Rungger-Brandle E, Dosso AA, &, Leuenberger PM, (2000): Glial reactivity, an early feature of diabetic retinopathy. Invest Ophthalmol Vis Sci 41: 1971-1980.
49. Scott IU, Jackson GR, Quillen DA, Klein R, Liao J, &, Gardner TW, (2014): Effect of doxycycline versus placebo on retinal function and diabetic retinopathy progression in mild to moderate nonproliferative diabetic retinopathy: a randomized proof-of-concept clinical trial. JAMA Ophthalmol 132: 1137-1142.
50. Sharma RK, Rogojina AT, &, Chalam KV, (2009): Multiplex immunoassay analysis of biomarkers in clinically accessible quantities of human aqueous humor. Mol Vis 15: 60-69.
51. Sohn HJ, Han DH, Kim IT, Oh IK, Kim KH, Lee DY, &, Nam DH, (2011): Changes in aqueous concentrations of various cytokines after intravitreal triamcinolone versus bevacizumab for diabetic macular edema. Am J Ophthalmol 152: 686-694.
52. Tang J, &, Kern TS, (2011): Inflammation in diabetic retinopathy. Prog Retin Eye Res 30: 343-358.
53. Vujosevic S, &, Midena E, (2013): Retinal layers changes in human preclinical and early clinical diabetic retinopathy support early retinal neuronal and Müller cells alterations. J Diabetes Res 2013: 905058.
54. Vujosevic S, Bini S, Midena G, Berton M, Pilotto E, &, Midena E, (2013): Hyperreflective intraretinal spots in diabetics without and with nonproliferative diabetic retinopathy: an in vivo study using spectral domain OCT. J Diabetes Res 2013: 491835.
55. Wilkinson CP, Ferris FL 3rd, Klein RE, et al., (2003): Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110: 1677-1682.
56. Yang LP, Sun H, Wu L, Guo XJ, Dou HL, Tso MO, Zhao L, &, Li SM, (2009): Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy. Invest Ophthalmol Vis Sci 50: 2319-2327.
57. Yoshida S, Yoshida A, Ishibashi T, Elner SG, &, Elner VM, (2003): Role of MCP-1 and MIP-1alpha in retinal neovascularization during postischemic inflammation in a mouse model of retinal neovascularization. J Leukoc Biol 73: 137-144.
58. Zeng X, Ng Y, &, Ling E, (2000): Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats. Vis Neurosci 17: 463-471.
59. Zeng HY, Green WR, &, Tso MO, (2008): Microglial activation in human diabetic retinopathy. Arch Ophthalmol 126: 227-232.
60. Zhang W, Liu H, Al-Shabrawey M, Caldwell RW, &, Caldwell RB, (2011): Inflammation and diabetic retinal microvascular complications. J Cardiovasc Dis Res 2: 96-103.
61. Zhou J, Wang S, &, Xia X, (2012): Role of intravitreal inflammatory cytokines and angiogenic factors in proliferative diabetic retinopathy. Curr Eye Res 37: 416-420.
62. Zong H, Ward M, &, Stitt AW, (2011): AGEs, RAGE, and diabetic retinopathy. Curr Diab Rep 11: 244-252.